Tech Company Financing Transactions
Aiko Biotechnology Funding Round
Action Equity, Small Enterprise Growth Fund and SV Health Investors participated in a $1.2 million Series A venture round for Aiko Biotechnology. The financing was announced on 12/8/2009.
Transaction Overview
Company Name
Announced On
12/8/2009
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Series A
Investors
Proceeds Purpose
The capital primarily will be used to complete a second human clinical trial using the FDA's exploratory IND mechanism and continue research on AIKOs promising portfolio of compounds.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Union St. 501
Portland, ME 04101
USA
Portland, ME 04101
USA
Phone
Website
Email Address
Overview
AIKO Biotechnology is a start-up biotechnology company based in Portland, ME focused on the discovery and validation of novel compounds for the treatment of pain and the side effects associated with prescription pain reliever (opioid) use such as GI dysfunction, addiction and abuse.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim New
Chief Operating Officer
Janet Yancey-Wrona
Chief Scientific Officer
Wolfgang Sadee
Browse more venture capital transactions:
Prev: 12/8/2009: SEQUANS Communications venture capital transaction
Next: 12/8/2009: Therasis venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs